Motor Neuron Diseases: Patient-reported outcomes
Patient-reported outcomes after stem cell therapy for Motor Neuron Diseases, based on 59 patients in our follow-up registry.
Updated ·
Overall patient-reported outcomes
Physical condition
reported physical improvement
65%
N = 54
Quality of life
reported quality-of-life improvement
64%
N = 55
Treatment satisfaction
satisfied with the treatment outcome
63%
N = 54
Reported change vs. before treatment
Worse No change Small Moderate Significant
| Symptom | Reported change vs. before treatment | Reported improvement |
|---|---|---|
| Speech (babbling for infants) | | 63% |
| Movement in general | | 49% |
| Spasticity | | 47% |
| Interaction with others | | 47% |
| Energy | | 46% |
| General mental ability | | 45% |
| Appetite | | 44% |
| Standing up | | 43% |
| Range of movement | | 43% |
| Breathing | | 43% |
| Cooperation with others | | 42% |
| Overall strength | | 42% |
| Trunk control | | 41% |
| Balance | | 40% |
| Trunk muscle strength | | 38% |
| Limb muscle strength | | 38% |
| Walking | | 35% |
| Swallowing | | 32% |
About this data
Patients self-assess each symptom on a 5-point scale (Worse / No improvement / Small / Moderate / Significant) at follow-up checkpoints after treatment, comparing to their pre-treatment baseline. "Reported improvement" combines the small, moderate and significant buckets. Data is updated daily from our internal patient registry. As with any medical treatment, past results do not guarantee future outcomes — improvements vary from patient to patient.
